564 related articles for article (PubMed ID: 18930646)
1. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
2. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
Jorquera J; Díaz O; Lisboa C
Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
[TBL] [Abstract][Full Text] [Related]
3. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD.
Berton DC; Barbosa PB; Takara LS; Chiappa GR; Siqueira AC; Bravo DM; Ferreira LF; Neder JA
Thorax; 2010 Jul; 65(7):588-93. PubMed ID: 20627914
[TBL] [Abstract][Full Text] [Related]
5. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
6. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
9. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
[TBL] [Abstract][Full Text] [Related]
10. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
11. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
[TBL] [Abstract][Full Text] [Related]
12. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
[TBL] [Abstract][Full Text] [Related]
13. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
Walker PP; Calverley PM
COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
[TBL] [Abstract][Full Text] [Related]
14. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette JA; Raghavan N; Harris-McAllister V; Preston ME; Webb KA; O'Donnell DE
Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
16. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
18. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207
[TBL] [Abstract][Full Text] [Related]
20. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]